{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Insulin+aspart&page=2", "query": { "intervention": "Insulin aspart", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 180, "total_pages": 18, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Insulin+aspart&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Insulin+aspart&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-03T08:50:17.509Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03336528", "title": "Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Degludec", "type": "DRUG" }, { "name": "Glargine", "type": "DRUG" }, { "name": "Aspart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2018-01-02", "completion_date": "2021-03-01", "has_results": true, "last_update_posted_date": "2022-03-31", "last_synced_at": "2026-10-03T08:50:17.509Z", "location_count": 4, "location_summary": "Atlanta, Georgia • New York, New York • Spokane, Washington", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "New York", "state": "New York" }, { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03336528" }, { "nct_id": "NCT00097877", "title": "Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "biphasic insulin aspart", "type": "DRUG" }, { "name": "insulin glargine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 293, "start_date": "2005-01", "completion_date": "2006-11", "has_results": false, "last_update_posted_date": "2017-01-11", "last_synced_at": "2026-10-03T08:50:17.509Z", "location_count": 71, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Vestavia Hills, Alabama + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Vestavia Hills", "state": "Alabama" }, { "city": "Searcy", "state": "Arkansas" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00097877" }, { "nct_id": "NCT03874715", "title": "Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Insulin Aspart SAR341402", "type": "DRUG" }, { "name": "Insulin Aspart", "type": "DRUG" }, { "name": "Insulin glargine U100", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2019-03-11", "completion_date": "2020-07-08", "has_results": true, "last_update_posted_date": "2024-04-17", "last_synced_at": "2026-10-03T08:50:17.509Z", "location_count": 33, "location_summary": "Concord, California • Temecula, California • Ventura, California + 30 more", "locations": [ { "city": "Concord", "state": "California" }, { "city": "Temecula", "state": "California" }, { "city": "Ventura", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Waterbury", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03874715" }, { "nct_id": "NCT03262116", "title": "Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Humalog", "type": "DRUG" }, { "name": "Novolog", "type": "DRUG" }, { "name": "BC222 insulin lispro", "type": "DRUG" }, { "name": "Bionic Pancreas", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2019-03-19", "completion_date": "2019-07-23", "has_results": true, "last_update_posted_date": "2022-12-09", "last_synced_at": "2026-10-03T08:50:17.509Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03262116" }, { "nct_id": "NCT00428207", "title": "Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Insulin Aspart versus Insulin Lispro", "type": "DRUG" }, { "name": "Insulin Lispro versus Insulin Aspart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Joslin Diabetes Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 4, "start_date": "2007-02", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-10-03T08:50:17.509Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00428207" }, { "nct_id": "NCT01365507", "title": "Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "insulin degludec/insulin aspart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 276, "start_date": "2011-06", "completion_date": "2012-04", "has_results": true, "last_update_posted_date": "2017-03-17", "last_synced_at": "2026-10-03T08:50:17.509Z", "location_count": 25, "location_summary": "Concord, California • Los Angeles, California • Montclair, California + 20 more", "locations": [ { "city": "Concord", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Montclair", "state": "California" }, { "city": "Palm Springs", "state": "California" }, { "city": "Spring Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01365507" }, { "nct_id": "NCT00590226", "title": "Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Detemir + aspart insulin before meals", "type": "DRUG" }, { "name": "NPH insulin + regular insulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 130, "start_date": "2006-12", "completion_date": "2008-04", "has_results": true, "last_update_posted_date": "2014-06-11", "last_synced_at": "2026-10-03T08:50:17.509Z", "location_count": 2, "location_summary": "Atlanta, Georgia • Chicago, Illinois", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00590226" }, { "nct_id": "NCT01713530", "title": "A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "insulin degludec/insulin aspart", "type": "DRUG" }, { "name": "insulin degludec", "type": "DRUG" }, { "name": "insulin aspart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 274, "start_date": "2013-02-21", "completion_date": "2014-01-09", "has_results": true, "last_update_posted_date": "2018-04-02", "last_synced_at": "2026-10-03T08:50:17.509Z", "location_count": 26, "location_summary": "Greenbrae, California • Mission Hills, California • San Diego, California + 22 more", "locations": [ { "city": "Greenbrae", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Kissimmee", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01713530" }, { "nct_id": "NCT05946785", "title": "Oxidative Stress in Microvascular Dysfunction Following Gestational Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Gestational Diabetes", "Vascular Endothelial Function" ], "interventions": [ { "name": "Acetylcholine", "type": "DRUG" }, { "name": "insulin aspart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Anna Stanhewicz, PhD", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 28, "start_date": "2023-07-01", "completion_date": "2027-06-01", "has_results": false, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-10-03T08:50:17.509Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT05946785" }, { "nct_id": "NCT01966978", "title": "The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes Mellitus, Type 2", "Diabetes" ], "interventions": [ { "name": "Metformin", "type": "DRUG" }, { "name": "Detemir", "type": "DRUG" }, { "name": "Liraglutide", "type": "DRUG" }, { "name": "Insulin Aspart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 157, "start_date": "2014-11", "completion_date": "2017-12", "has_results": true, "last_update_posted_date": "2019-10-22", "last_synced_at": "2026-10-03T08:50:17.509Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01966978" } ] }